V015-1324 Screening compound: 1-[4-(4-METHYLPIPERAZIN-1-YL)-2-(PYRROLIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-6-YL]-2-PHENYLETHAN-1-ONE

V015-1324 Screening compound: 1-[4-(4-METHYLPIPERAZIN-1-YL)-2-(PYRROLIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-6-YL]-2-PHENYLETHAN-1-ONE
V015-1324 Screening compound: 1-[4-(4-METHYLPIPERAZIN-1-YL)-2-(PYRROLIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-6-YL]-2-PHENYLETHAN-1-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-1324
1-[4-(4-METHYLPIPERAZIN-1-YL)-2-(PYRROLIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-6-YL]-2-PHENYLETHAN-1-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-1324

Molecular Formula

C24H32N6O (C24 H32 N6 O)

Compound Name

1-[4-(4-METHYLPIPERAZIN-1-YL)-2-(PYRROLIDIN-1-YL)-5H,6H,7H,8H-PYRIDO[4,3-D]PYRIMIDIN-6-YL]-2-PHENYLETHAN-1-ONE

IUPAC name

n/a

SMILES

CN(CC1)CCN1c1c(CN(CC2)C(Cc3ccccc3)=O)c2nc(N2CCCC2)n1

InChI

InChI=1S/C24H32N6O/c1-27-13-15-28(16-14-27)23-20-18-30(22(31)17-19-7-3-2-4-8-19)12-9-21(20)25-24(26-23)29-10-5-6-11-29/h2-4,7-8H,5-6,9-18H2,1H3

InChI Key

HRQDFJZSLVIABZ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19932901

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

420.56

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.248

Distribution Coefficient, logD

2.067

Water Solubility, LogSw

-3.41

Polar Surface Area

45.701

Acid Dissociation Constant (pKa)

17.36

Base Dissociation Constant (pKb)

8.55

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

V015-1324 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V015-1324 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-1324?
Check Price and Availability of V015-1324, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-1324 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-1324
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-1324
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-1324 available by request